Cargando…

583. Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV

BACKGROUND: Mental health (MH) conditions and pain are common among people living with HIV (PLWH). An understanding of factors associated with prescriptions for these conditions and clinical impact of the prescriptions may improve care of MH disorders in PLWH. METHODS: The use of mental health/pain-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathur, Swati, Roberts-Toler, Carla, Tassiopoulos, Katherine, Goodkin, Karl, McLaughin, Mirena, Koletar, Susan, Erlandson, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254767/
http://dx.doi.org/10.1093/ofid/ofy210.590
_version_ 1783373800597880832
author Mathur, Swati
Roberts-Toler, Carla
Tassiopoulos, Katherine
Goodkin, Karl
McLaughin, Mirena
Koletar, Susan
Erlandson, Kristine
author_facet Mathur, Swati
Roberts-Toler, Carla
Tassiopoulos, Katherine
Goodkin, Karl
McLaughin, Mirena
Koletar, Susan
Erlandson, Kristine
author_sort Mathur, Swati
collection PubMed
description BACKGROUND: Mental health (MH) conditions and pain are common among people living with HIV (PLWH). An understanding of factors associated with prescriptions for these conditions and clinical impact of the prescriptions may improve care of MH disorders in PLWH. METHODS: The use of mental health/pain-related medications was examined among PLWH within the AIDS Clinical Trials Group A5322 (HAILO) study. Use of medications (any use and class) was compared by sex. Multivariable logistic models estimated the association between MH medications (any/none) with (i) insurance status and race/ethnicity and (ii) baseline and incident slow gait (>1 second/m) and neurocognitive impairment (NCI) over 4 years. RESULTS: Of 1035 participants, the median age was 51. 81% were men, 30% black, and 20% Hispanic. Similar numbers of men (34%) and women (38%) were on MH medications (P = 0.19).Women were more likely to be prescribed opioids (12% vs. 5%; P < 0.001); other classes were similar. In multivariable models, MH-medicated PLWH were more likely to have Medicare (odds ratio [OR] 2.50, 95% CI 1.50–4.16, P < 0.001) or public insurance (1.85; 1.23–2.78, P = 0.003) vs. no/unknown insurance; and less likely to be Hispanic vs. white (0.48; 0.33–0.69; P < 0.001). MH-medicated PLWH had greater odds of baseline slow gait (1.80; 1.34–2.40; P < 0.001). The sex-specific ORs for NCI were qualitatively different (men: 1.70; 1.09–2.66; women: 0.96; 0.43–2.18); but this difference was not significant in the multivariable model (P interaction = 0.227). There was an increased risk of incident slow gait among MH-medicated men but not women (hazard ratio 1.74; 1.22–2.48 vs. 0.76; 0.38–1.52, P interaction = 0.038), and a trend toward increased risk of incident NCI (1.76; 0.91, 3.39, P = 0.09) for both sexes. CONCLUSION: Our results highlight socioeconomic and ethnic differences in prescription of MH medications. The higher proportion of opiate prescriptions among women needs confirmation and should be a priority for intervention. The greater risk of baseline NCI and incident slow gait among men may be the result of differences in toxicity, drug interactions, or persistent mental health symptoms; further investigation is needed to optimize outcomes in PLWH and prescription of mental health medications. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254767
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62547672018-11-28 583. Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV Mathur, Swati Roberts-Toler, Carla Tassiopoulos, Katherine Goodkin, Karl McLaughin, Mirena Koletar, Susan Erlandson, Kristine Open Forum Infect Dis Abstracts BACKGROUND: Mental health (MH) conditions and pain are common among people living with HIV (PLWH). An understanding of factors associated with prescriptions for these conditions and clinical impact of the prescriptions may improve care of MH disorders in PLWH. METHODS: The use of mental health/pain-related medications was examined among PLWH within the AIDS Clinical Trials Group A5322 (HAILO) study. Use of medications (any use and class) was compared by sex. Multivariable logistic models estimated the association between MH medications (any/none) with (i) insurance status and race/ethnicity and (ii) baseline and incident slow gait (>1 second/m) and neurocognitive impairment (NCI) over 4 years. RESULTS: Of 1035 participants, the median age was 51. 81% were men, 30% black, and 20% Hispanic. Similar numbers of men (34%) and women (38%) were on MH medications (P = 0.19).Women were more likely to be prescribed opioids (12% vs. 5%; P < 0.001); other classes were similar. In multivariable models, MH-medicated PLWH were more likely to have Medicare (odds ratio [OR] 2.50, 95% CI 1.50–4.16, P < 0.001) or public insurance (1.85; 1.23–2.78, P = 0.003) vs. no/unknown insurance; and less likely to be Hispanic vs. white (0.48; 0.33–0.69; P < 0.001). MH-medicated PLWH had greater odds of baseline slow gait (1.80; 1.34–2.40; P < 0.001). The sex-specific ORs for NCI were qualitatively different (men: 1.70; 1.09–2.66; women: 0.96; 0.43–2.18); but this difference was not significant in the multivariable model (P interaction = 0.227). There was an increased risk of incident slow gait among MH-medicated men but not women (hazard ratio 1.74; 1.22–2.48 vs. 0.76; 0.38–1.52, P interaction = 0.038), and a trend toward increased risk of incident NCI (1.76; 0.91, 3.39, P = 0.09) for both sexes. CONCLUSION: Our results highlight socioeconomic and ethnic differences in prescription of MH medications. The higher proportion of opiate prescriptions among women needs confirmation and should be a priority for intervention. The greater risk of baseline NCI and incident slow gait among men may be the result of differences in toxicity, drug interactions, or persistent mental health symptoms; further investigation is needed to optimize outcomes in PLWH and prescription of mental health medications. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254767/ http://dx.doi.org/10.1093/ofid/ofy210.590 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Mathur, Swati
Roberts-Toler, Carla
Tassiopoulos, Katherine
Goodkin, Karl
McLaughin, Mirena
Koletar, Susan
Erlandson, Kristine
583. Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV
title 583. Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV
title_full 583. Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV
title_fullStr 583. Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV
title_full_unstemmed 583. Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV
title_short 583. Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV
title_sort 583. demographic factors and clinical outcomes associated with mental health medication use in people living with hiv
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254767/
http://dx.doi.org/10.1093/ofid/ofy210.590
work_keys_str_mv AT mathurswati 583demographicfactorsandclinicaloutcomesassociatedwithmentalhealthmedicationuseinpeoplelivingwithhiv
AT robertstolercarla 583demographicfactorsandclinicaloutcomesassociatedwithmentalhealthmedicationuseinpeoplelivingwithhiv
AT tassiopouloskatherine 583demographicfactorsandclinicaloutcomesassociatedwithmentalhealthmedicationuseinpeoplelivingwithhiv
AT goodkinkarl 583demographicfactorsandclinicaloutcomesassociatedwithmentalhealthmedicationuseinpeoplelivingwithhiv
AT mclaughinmirena 583demographicfactorsandclinicaloutcomesassociatedwithmentalhealthmedicationuseinpeoplelivingwithhiv
AT koletarsusan 583demographicfactorsandclinicaloutcomesassociatedwithmentalhealthmedicationuseinpeoplelivingwithhiv
AT erlandsonkristine 583demographicfactorsandclinicaloutcomesassociatedwithmentalhealthmedicationuseinpeoplelivingwithhiv